| Dr Judson Daniell Rackley, MD | |
|
200 Johnson Ridge Medical Park, Elkin, NC 28621-2443 | |
| (336) 526-0040 | |
| Not Available |
| Full Name | Dr Judson Daniell Rackley |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 23 Years |
| Location | 200 Johnson Ridge Medical Park, Elkin, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578583829 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 2018-02609 (North Carolina) | Primary |
| 208800000X | Urology | ME0095219 (Florida) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hugh Chatham Memorial Hospital | Elkin, NC | Hospital |
| Novant Health Forsyth Medical Center | Winston-salem, NC | Hospital |
| Novant Health Medical Park Hospital | Winston-salem, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hugh Chatham Memorial Hospital Inc | 2062311442 | 87 |
| Piedmont Stone Center Pllc | 2961315718 | 61 |
| Forsyth Memorial Hospital Inc | 9537071790 | 531 |
News Archive
Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a condition where blood clots form in the veins) directly after they have been treated with a blood thinner given by injection for at least five days.
Bruker Corporation (NASDAQ: BRKR) announced today, the evolution of their maXis™ line of ultrahigh-resolution quadrupole time-of-flight (UHR-qTOF) mass spectrometers, bringing industry-leading resolution and mass accuracy to the liquid chromatography, time-of-flight MS market space.
Today's headlines include stories previewing how health policy issues will fit into the Supreme Court's new term.
Patterson Companies, Inc. today reported consolidated sales of $812,762,000 for the fourth quarter of fiscal 2010 ended April 24, an increase of 4% from $779,884,000 in the year-earlier quarter. Internal growth accounted for 1% of the fourth quarter sales increase, with acquisitions and foreign currency adjustments accounting for the balance.
› Verified 7 days ago
| Entity Name | Piedmont Stone Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700827409 PECOS PAC ID: 2961315718 Enrollment ID: O20031107000688 |
News Archive
Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a condition where blood clots form in the veins) directly after they have been treated with a blood thinner given by injection for at least five days.
Bruker Corporation (NASDAQ: BRKR) announced today, the evolution of their maXis™ line of ultrahigh-resolution quadrupole time-of-flight (UHR-qTOF) mass spectrometers, bringing industry-leading resolution and mass accuracy to the liquid chromatography, time-of-flight MS market space.
Today's headlines include stories previewing how health policy issues will fit into the Supreme Court's new term.
Patterson Companies, Inc. today reported consolidated sales of $812,762,000 for the fourth quarter of fiscal 2010 ended April 24, an increase of 4% from $779,884,000 in the year-earlier quarter. Internal growth accounted for 1% of the fourth quarter sales increase, with acquisitions and foreign currency adjustments accounting for the balance.
› Verified 7 days ago
| Entity Name | Novant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366409492 PECOS PAC ID: 1153234893 Enrollment ID: O20031121000692 |
News Archive
Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a condition where blood clots form in the veins) directly after they have been treated with a blood thinner given by injection for at least five days.
Bruker Corporation (NASDAQ: BRKR) announced today, the evolution of their maXis™ line of ultrahigh-resolution quadrupole time-of-flight (UHR-qTOF) mass spectrometers, bringing industry-leading resolution and mass accuracy to the liquid chromatography, time-of-flight MS market space.
Today's headlines include stories previewing how health policy issues will fit into the Supreme Court's new term.
Patterson Companies, Inc. today reported consolidated sales of $812,762,000 for the fourth quarter of fiscal 2010 ended April 24, an increase of 4% from $779,884,000 in the year-earlier quarter. Internal growth accounted for 1% of the fourth quarter sales increase, with acquisitions and foreign currency adjustments accounting for the balance.
› Verified 7 days ago
| Entity Name | Forsyth Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104548874 PECOS PAC ID: 9537071790 Enrollment ID: O20040405001702 |
News Archive
Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a condition where blood clots form in the veins) directly after they have been treated with a blood thinner given by injection for at least five days.
Bruker Corporation (NASDAQ: BRKR) announced today, the evolution of their maXis™ line of ultrahigh-resolution quadrupole time-of-flight (UHR-qTOF) mass spectrometers, bringing industry-leading resolution and mass accuracy to the liquid chromatography, time-of-flight MS market space.
Today's headlines include stories previewing how health policy issues will fit into the Supreme Court's new term.
Patterson Companies, Inc. today reported consolidated sales of $812,762,000 for the fourth quarter of fiscal 2010 ended April 24, an increase of 4% from $779,884,000 in the year-earlier quarter. Internal growth accounted for 1% of the fourth quarter sales increase, with acquisitions and foreign currency adjustments accounting for the balance.
› Verified 7 days ago
| Entity Name | Hugh Chatham Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447373063 PECOS PAC ID: 2062311442 Enrollment ID: O20040717000340 |
News Archive
Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a condition where blood clots form in the veins) directly after they have been treated with a blood thinner given by injection for at least five days.
Bruker Corporation (NASDAQ: BRKR) announced today, the evolution of their maXis™ line of ultrahigh-resolution quadrupole time-of-flight (UHR-qTOF) mass spectrometers, bringing industry-leading resolution and mass accuracy to the liquid chromatography, time-of-flight MS market space.
Today's headlines include stories previewing how health policy issues will fit into the Supreme Court's new term.
Patterson Companies, Inc. today reported consolidated sales of $812,762,000 for the fourth quarter of fiscal 2010 ended April 24, an increase of 4% from $779,884,000 in the year-earlier quarter. Internal growth accounted for 1% of the fourth quarter sales increase, with acquisitions and foreign currency adjustments accounting for the balance.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Judson Daniell Rackley, MD 360 Parkwood Medical Park, Elkin, NC 28621-2444 Ph: () - | Dr Judson Daniell Rackley, MD 200 Johnson Ridge Medical Park, Elkin, NC 28621-2443 Ph: (336) 526-0040 |
News Archive
Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a condition where blood clots form in the veins) directly after they have been treated with a blood thinner given by injection for at least five days.
Bruker Corporation (NASDAQ: BRKR) announced today, the evolution of their maXis™ line of ultrahigh-resolution quadrupole time-of-flight (UHR-qTOF) mass spectrometers, bringing industry-leading resolution and mass accuracy to the liquid chromatography, time-of-flight MS market space.
Today's headlines include stories previewing how health policy issues will fit into the Supreme Court's new term.
Patterson Companies, Inc. today reported consolidated sales of $812,762,000 for the fourth quarter of fiscal 2010 ended April 24, an increase of 4% from $779,884,000 in the year-earlier quarter. Internal growth accounted for 1% of the fourth quarter sales increase, with acquisitions and foreign currency adjustments accounting for the balance.
› Verified 7 days ago
Dominick John Carbone Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 200 Johnson Ridge Medical Park, Elkin, NC 28621 Phone: 336-526-0040 Fax: 336-526-0043 |